Company intelligence / Profile preview

Talking Medicines

Glasgow, Scotland, United Kingdom

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Talking Medicines is a data technology company that provides pharmaceutical companies with deep insights into patient experiences and sentiments. Utilizing advanced artificial intelligence and natural language processing, the company's PatientMapper platform analyzes unstructured data from social media and online communities to map the patient journey at a drug-specific level. This Patient Intelligence helps pharma brands understand real-world drug usage, adherence issues, and quality of life impacts. By translating the patient voice into actionable data, Talking Medicines enables more effective marketing strategies and patient-centric drug development.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Talking Medicines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Talking Medicines.

Explore the full profile